text:
I can remember vividly being a high school student, anticipating the feeling of relief as I prepared for my final examination. I wanted to move on, thinking very little about any future events beyond playing sports and hanging out with my friends. I did not consider the ripple effects of learning or not learning.
Imagine throwing a pebble deep into the center of a crystal clear pond. The result is ripples that wave one after another throughout the pond, deep from the center, slowly to the periphery.
Whether you want to hear it or not, your choice to both prepare for your final examination and apply what you have learned in this class to your everyday lives is much like the pebble hitting the pond. Your future financial choices will send a wave deep into every aspect of your life and the lives of others.
Your first wave will begin just after high school with your post-education choices and subsequent college debt. While at the same time, you will be testing your discipline with a credit card and future car debt.
Before you know it, you will be a young professional deciding whether to fill your bartenders' pockets with your discretionary income or fill your own future pockets by adequately investing for retirement.
Sooner than you may imagine, it will shape your family's quality of life and your subsequent peace of mind.
Eventually, it will guide your opportunity to reach financial freedom at a young enough age to enjoy retirement as others struggle to live on a fixed income, working well into their seventies.
In the periphery, lies the legacy for your future children, and your ability to prepare them for a world full of financial trickery and hidden wealth.
Just as the ripples in the pond get bigger and bigger, so will your financial responsibilities. Being financially responsible is not the result of a high school or college course, nor is it the result of being disciplined and conscience of your choices. It has to be both, and your financial education has to be ongoing.
Now as you have envisioned what you can expect as you move forward, I want you to imagine the waves of choices you will be faced with in a different lens. For a moment, envision shouldering a responsibility much greater than your own financial future. For this moment - - internalize your responsibility as a next generation American.
Our country desperately needs waves of economic change that will transform where we are and the direction we are heading. Our country needs a generation full of financially astute and responsible leadership that will guide us out of consumer and government debt massive enough to change the United States as we know it.
My challenge for you is to understand how to responsibly manage the waves of financial challenges that you will face throughout your life, while making waves for your country that will better the lives of the generations to come.
Let what you have learned in this course be the pebble that creates the first wave of change that we all need.


text:
Price: $16.00
Size: 9 oz
Other Sizes: 33.8 ounce
A favorite of celebrities and Malibuites alike, this 100% vegan shampoo keeps natural and bleached blondes bright with deep moisturizing capabilities and a stellar signature scent that will have you dreaming of a tropical island paradise.
Following shampooing with Malibu Blondes® Wellness Shampoo, condition with Malibu Blondes® Wellness Conditioner.
Water/Aqua/Eau, Sodium Lauroyl Sarcosinate, Decyl Glucoside, PEG-120 Methyl Glucose Dioleate, Polysorbate 20, Butylene Glycol, Sodium Lauroyl Lactylate, Panthenol, Glycerin, Hydrolyzed Rice Protein, PEG-16 Macadamia Glycerides, Disodium EDTA, Allantoin, Linum Usitatissimum Seed Extract, Polyquaternium 10, Fragrance/Parfum, Sodium Gluconate, Citric Acid, Potassium Sorbate, Phenoxyethanol, Limonene.
• • •
All content on this site is for information only and is not intended to substitute for the advice available from your own medical professional. The information contained herein should not be used as a medical diagnosis and should not be used as prescription for any medication. It is very important to read the information on every product package. If you have or suspect a medical problem, you should promptly contact your health care provider. Claims made above have not been reviewed by FDA.
Malibu Wellness' vitamin technology is a patented technology protected by patent #5,804,172.

subset: commoncrawl


text:
Engineering in Medicine Symposium - Participant Biographies
Pamela Bagley
Pamela Bagley is a Research and Education Librarian at Dartmouth Biomedical Libraries. She regularly teaches evidence based practice principles to medical students and clinicians. In 2006, she participated in the "Workshop on Evidence Based Practice" at the Oxford Centre for Evidence-Based Practice. Pamela has participated on the planning committee and as a faculty librarian in the annual three-day "Dartmouth Summer Institute in Evidence-Based Psychiatry and Mental Health" since it began in 2006. She also participated on the planning committee and as faculty for "Supporting Clinical Care: An Institute in Evidence-Based Practice for Medical Librarians" held in August, 2008. In March, 2008 she spent ten days giving talks and leading workshops and hands-on sessions for clinicians at the National Children's Hospital in Hanoi, Vietnam. Pamela's background as a research scientist gives her extensive experience in designing, evaluating and appraising research studies.
Paul B. Batalden, M.D.
Paul B. Batalden, M.D., is the Director of the Center for Leadership and Improvement at The Dartmouth Institute for Health Policy and Clinical Practice (formerly the Center for the Evaluative Clinical Sciences) and Professor of Pediatrics and of Community and Family Medicine at Dartmouth Medical School. Dr. Batalden leads the creation and delivery of educational opportunities for physicians, nurses, healthcare workers, healthcare administrators and their teachers about the improvement of the quality, value and safety of health care. He is the Program Director of the Dartmouth-Hitchcock Leadership Preventive Medicine Residency program, which is a residency program that combines a specialty residency with the Leadership Preventive Medicine residency at Dartmouth-Hitchcock Medical Center. He co-directs the Veteran's Administration National Quality Scholars program--a two-year special fellowship for physicians who have completed their specialty training and who wish to become teachers and researchers in the improvement of the quality, safety and value of health care. Dr. Batalden also serves as the Senior Vice-President for Health Professional Development of the Institute for Healthcare Improvement, a position he took after serving as the founding chairman of the IHI Board. He is the Chair of the IHI Health Professions Education Collaborative whose aim is to prepare health professionals to lead the continual improvement of the quality, safety and value of health care. Dr. Batalden is the Project Director of the Robert Wood Johnson Foundation Publication Guidelines Grant (SQUIRE).
John Collier, D.E.
John Collier, D.E., is the Myron Tribus Professor of Engineering at Thayer School of Engineering at Dartmouth. He is a member of the Society for Biomaterials, the Orthopaedic Research Society and the American Academy of Orthopaedic Surgeons. Collier has been a research consultant for Canadian Oxygen, Ltd., DuPont Inc., and for DePuy, a Johnson and Johnson company. He has authored over 30 technical articles and delivered more than 50 conference presentations on aspects of orthopedic implant design and engineering. He also holds three patents for design or processes relating to orthopedic prostheses. His laboratory focuses on analysis and development of biomaterials for use in bone and joint implants.
Dr. Collier received his Bachelor of Arts from Dartmouth College, 1972, B.E. from Thayer School of Engineering in 1973, and M.S. and Doctor of Engineering at Thayer School of Engineering. At Thayer School he teaches the School's signature course, ENGS 21: Introduction to Engineering, as well as other courses in design methodology and biomaterials.
Joyce A. DeLeo, Ph.D.
Joyce A. DeLeo, Ph.D., is Professor and Chair of Pharmacology and Toxicology at the Dartmouth Medical School. She is currently the Irene Heinz Given Endowed Professor and Chair of Pharmacology and Toxicology. She was a member of the 2001-2002 Class of Fellows in the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program and received the first annual Graduate Faculty Mentoring Award from the Office of Graduate Studies, Dartmouth College in 2004. Dr. DeLeo has been instrumental in developing and directing the Neuroscience Center at Dartmouth, an interdisciplinary group whose mission is to foster collaborative and interactive research and education in the neurosciences. Dr. DeLeo was actively involved in the development of the recently established interdisciplinary graduate program, the Program in Experimental and Molecular Medicine (PEMM). The mission of Dr. DeLeo's laboratory is to better understand central nervous system and neuroimmune mechanisms that lead to chronic pain including neuropathic, inflammatory, post-operative and low back pain. This knowledge will translate into development of new, effective approaches for treatment and even prevention of these chronic pain syndromes. Dr. DeLeo serves on numerous NIH study sections, international grant review boards and editorial boards and has published over 130 peer-reviewed manuscripts, reviews and chapters.
Dr. DeLeo received her B.S. in Biology and Chemistry from the State University of New York at Albany in 1982 and a Ph.D. in Pharmacology from the University of Oklahoma Health Sciences Center in 1988. She did much of her pre-doctoral research at the Max Planck Institute of Psychiatry in Martinsried, W. Germany under a Fulbright scholarship investigating the effect of cerebral ischemia on an electrophysiological hippocampal slice preparation and the pharmacological intervention of in vivo ischemia. Dr. DeLeo did a post-doctoral fellowship at Harvard University, Department of Neuroscience, where she studied neonatal hypoxia and seizure susceptibility. She then came to Dartmouth as a post-doctoral fellow in the Anesthesia Research Laboratory.
Tillman Gerngross, Ph.D.
Tillman Gerngross, Ph.D., is a Professor of Bioengineering at the Thayer School of Engineering at Dartmouth College and an Adjunct Professor in the Department of Biology and Chemistry at Dartmouth. Gerngross has been an active inventor and to date his work has resulted in the founding of two companies (GlycoFi, Inc. and Adimab, Inc.) and over a dozen U.S. and International patents. His work has been frequently cited in the popular press including The Times (London), CNN, Scientific American, BBC, The Guardian, The Economist, New Scientist, Nature Biotechnology and the Los Angeles Times. He joined the faculty at Dartmouth in 1998 with a research focus on protein engineering, glycoprotein engineering in yeast, and life cycle analysis of competing manufacturing technologies. Gerngross developed a method for humanizing the glycosylation machinery in yeast to produce human therapeutic proteins, including antibodies, with fully human carbohydrate structures. Much of this work was conducted at Glycofi, Inc., a Lebanon, New Hampshire biotechnology startup company that was acquired in 2006 by Merck in a record-setting $400 million transaction.
Gerngross received a M.S. (Dipl. Ing.) in Chemical Engineering (1989) and later a Ph.D. in Molecular Biology from the Technical University of Vienna, Austria. Following his studies in Austria he became a visiting scientist at the Massachusetts Institute of Technology (Cambridge, MA) in the laboratory of Arnold Demain (1989-91) and later joined the laboratory of Anthony Sinskey and Joanne Stubbe at MIT as a Postdoctoral Associate from 1991 to 1993. From 1993 till 1998 he headed the fermentation and process development group at Metabolix Inc., a small startup company in Cambridge, MA.
Ashifi Gogo
Ashifi Gogo's venture into social entrepreneurship has continuously enjoyed a strong link with academia. At Whitman College on a full scholarship, Ashifi majored in mathematics and physics. Seeking a closer experience in implementing scientific solutions with a focus on the developing world, he entered Dartmouth College to pursue a Ph.D. in engineering with an emphasis on communication systems. At Dartmouth, he earned an Albert Schweitzer Fellowship by virtue of social enterprise, and honed his professional acumen with Six Sigma Black Belt training. Awards from the University of Washington, Seattle, the Claudio Chiuchiarelli Foundation, the Hong Kong University of Science and Technology and acceptance as a Fellow into America's first doctoral-level innovation program in recognition of technology-driven social enterprise have stimulated him towards excellence. As a co-founder and Chief Technologist of mPedigree, Gogo currently oversees the rollout of an innovative West-African drug quality assurance network that leverages the explosive growth of mobile phones in developing nations, allowing any consumer with a cell phone to verify the genuineness of medication before use, at no cost.
Karl Griswold, Ph.D.
Karl Griswold, Ph.D., is an Assistant Professor of Bioengineering at the Thayer School of Engineering at Dartmouth College and an Adjunct Assistant Professor in the Department of Biological Sciences at Dartmouth. Karl's work in the field of combinatorial protein engineering has resulted in the development of novel strategies for gene library construction and new approaches to high throughput screening of recombinant enzyme libraries. At the Thayer School, his research group is seeking to develop and utilize tools for evolutionary protein engineering while placing a priority on designing therapeutic enzymes with practical utility in treating human disease. In August of 2008, he received a Wallace H. Coulter Foundation Early Career Translational Research Award in Biomedical Engineering for research relating to development of enzymatic antibacterial therapies.
Karl studied as a DOW Foundation Scholar at Texas State University, earning a B.S. in chemistry in 1995. After working for two years with Thermo Electron Corporation and two years with Huntsman Corporation, he returned to academia receiving a Ph.D. in chemistry from the University of Texas at Austin in 2005. He then worked as a postdoctoral fellow with George Georgiou in the department of chemical engineering before joining the Thayer School of Engineering faculty in June of 2007.
Joseph J. Helble, Ph.D.
Joseph J. Helble, Ph.D., is Professor of Engineering and the 12th Dean of the Thayer School of Engineering at Dartmouth College. Prior to joining Dartmouth in 2005, Dr. Helble was the Roger Revelle Fellow of the American Association for the Advancement of Science (AAAS), enabling him to spend an academic year addressing technology and environmental policy issues in the office of U.S. Senator Joe Lieberman.
Previously, Dr. Helble was a member and later chair of the Department of Chemical Engineering at the University of Connecticut, with research in the areas of air pollution, CO2 capture, aerosols, and nanoscale materials production. He also initiated what has become a campus-wide program to produce biodiesel fuel from waste vegetable oil. From 1987-1995, he was employed as a research scientist and manager at Physical Sciences Inc. in Andover MA, specializing in environmental and energy technology development. In 1993, he also worked at U.S. EPA headquarters in Washington DC as a science and policy fellow of AAAS.
Dr. Helble has served on several EPA Science Advisory Board panels, and is presently on the editorial boards of two scientific journals. He is also a member of the Board of Advisors of the University of Vermont College of Engineering and Mathematical Sciences. Dr. Helble is the author of over 100 publications in the areas of air pollution, aerosols, nanoscale ceramics, and air quality, and 3 U.S. patents related to nanoscale powder production. He was a recipient of a young faculty Career Award from NSF, an outstanding young faculty award from the University of Connecticut School of Engineering, and the inaugural environmental faculty leadership award from the University of Connecticut.
Dr. Helble is a 1982 summa cum laude chemical engineering graduate of Lehigh University and a 1987 chemical engineering Ph.D. graduate of the Massachusetts Institute of Technology.
C. Everett Koop, M.D.
Dr. C. Everett Koop, M.D., graduated from Dartmouth College in 1937 and received his M.D. degree from Cornell Medical College in 1941. After serving an internship at the Pennsylvania Hospital, he pursued postgraduate training at the University of Pennsylvania School of Medicine, the Boston Children's Hospital, and the Graduate School of Medicine at the University of Pennsylvania, where he received the degree of Doctor of Science (Medicine) in 1947. He was named Professor of Pediatric Surgery at the School of Medicine of the University of Pennsylvania in 1959, and later Professor of Pediatrics in 1971. He is presently the Elizabeth DeCamp McInerny Professor at Dartmouth.
An internationally respected pediatric surgeon, Dr. Koop became Surgeon-in-Chief of the Children's Hospital of Philadelphia in 1948 and served in that capacity until 1981. He was the Editor-in-Chief of the Journal of Pediatric Surgery from 1964-1976. Dr. Koop was appointed Deputy Assistant Secretary for Health, U.S. Public Health Service (PHS) in March 1981 and was sworn in as the U.S. Surgeon General on November 17, 1981 where he oversaw the activities of the 6,000 member PHS Commissioned Corps and advised the public on a variety of health matters: smoking, nutrition, environmental health hazards, AIDS and disease prevention. He was also appointed Director of the Office of International Health in May 1982. He resigned as Surgeon General on October 1, 1989 and continues to be a force for public health and health education through his writings, electronic media, public appearances, and as Senior Scholar of the C. Everett Koop Institute at Dartmouth. Dr. Koop has received numerous awards, including the nation's highest civilian award, the Presidential Medal of Freedom, and an Emmy Award for his TV series on health reform. He has written more than 200 articles and books on the practice of medicine and surgery, biomedical ethics, and health policy. In 1991 he was given an Emmy Award in the News and Documentary category for C. Everett Koop, M.D., a five part series on health care reform.
Robert Langer, Ph.D.
Robert Langer, Ph.D., is one of 13 Institute Professors (the highest honor awarded to a faculty member) at the Massachusetts Institute of Technology (MIT). Dr. Langer has written more than 1,000 articles. He also has more than 600 issued or pending patents worldwide. Dr. Langer's patents have been licensed or sublicensed to over 200 pharmaceutical, chemical, biotechnology and medical device companies. He served as a member of the United States Food and Drug Administration's SCIENCE Board, the FDA's highest advisory board, from 1995-2002 and as its Chairman from 1999-2002. Dr. Langer has received over 160 major awards including the 2006 United States National Medal of Science; the Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers and the 2008 Millennium Prize, the world's largest technology prize. In 1998, he received the Lemelson-MIT prize, the world's largest prize for invention for being "one of history's most prolific inventors in medicine." In 1989 Dr. Langer was elected to the Institute of Medicine of the National Academy of Sciences, and in 1992 he was elected to both the National Academy of Engineering and to the National Academy of Sciences. He is one of very few people ever elected to all three United States National Academies and the youngest in history (at age 43) to ever receive this distinction.
He received his Bachelor's Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering. To date, Dr. Langer has received honorary doctorates from Yale University, the ETH (Switzerland), the Technion (Israel), the Hebrew University of Jerusalem (Israel), the Universite Catholique de Louvain (Belgium), the University of Liverpool (England), the University of Nottingham (England), Albany Medical College, the Pennsylvania State University, Northwestern University and Uppsala University (Sweden).
Hilary Llewellyn-Thomas, Ph.D.
Hilary Llewellyn-Thomas, Ph.D., is Professor in the Department of Community & Family Medicine at Dartmouth Medical School (DMS). She serves as Co-Director of the Center for Informed Choice (CIC) in the Dartmouth Institute for Health Policy & Clinical Care (TDI). She also serves as founding Research Director of the Center for Shared Decision Making at Dartmouth-Hitchcock Medical Center. Her research particularly focuses on different approaches to "values clarification", during the process of helping patients make informed, preference-based choices, particularly in close-call situations that generate decisional distress. She also works on the fundamental measurement issues inherent in assessing patients' preferential attitudes about different health states; participation in decision making; the periods of time involved in treatment; and tradeoffs between the different risks & benefits inherent in competing optional therapies. For 10 years, before joining the faculty at Dartmouth in 2000, Dr. Llewellyn-Thomas was a Canadian National Health Research Scholar in the Canadian National Health Research & Development Program. She publishes extensively in the methodological literature about health care decision making. Dr. Llewellyn-Thomas has served as President of the Society for Medical Decision Making (SMDM), and is a recipient of the Society's John M. Eisenberg Award in Recognition of Exemplary Leadership in Practical Application of Medical Decision Making Research.
Terrance G. McGuire, M.S. MBA
Terry McGuire, M.S., MBA, is a co-founder and managing general partner of Polaris Venture Partners based in the Boston office. Terry focuses on life sciences investments. Prior to starting Polaris, Terry spent seven years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Terry began his career in venture capital at Golder, Thoma and Cressey in Chicago. Terry has co-founded three companies: Inspire Pharmaceuticals, Advanced Inhalation Research, Inc., and MicroCHIPS. Terry represents Polaris on the boards of directors of Acceleron Pharma, Biolex Therapeutics, Life Line Screening, Microbia, MicroCHIPS, and Remon Medical Technologies Inc. He has also represented Polaris on the boards of Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, deCODE, GlycoFi and Transform Pharmaceuticals.
In addition to chairing Thayer School's board, Terry also serves on the boards of the Private Equity and Entrepreneurship Center at the Tuck School, Dartmouth College; the National Venture Capital Association; the MIT Center for Cancer Research; the Whitehead Institute for Biomedical Research; and the Advisory Board of the Arthur Rock Center for Entrepreneurship, Harvard Business School. He is a former board member of the Massachusetts Biotechnology Council and MassMEDIC.
Terry holds an MBA from Harvard Business School, an M.S. from Thayer School of Engineering, and a B.S. from Hobart College. He was a Thomas J. Watson Fellow in 1979, studying Gaelic culture in Ireland. Terry is a recipient of the 2005 Albert Einstein Award for Outstanding Achievement in the Life Sciences, awarded by Forbes/Gottlieb Medical Technology Investor, Harvard MIT Biomedical Engineering Center, the New Jerusalem Foundation, the Jerusalem Development Authority, and Rodman and Renshaw.
Ronald S. Newbower, Ph.D.
Dr. Newbower, Ph.D., is Co-founder, Strategic Director and Chief Technology Officer of CIMIT, an innovative multi-institutional $12M-per-year Center designed to accelerate the development of cost-effective medical technologies. As the former Vice President for Research Management of Partners HealthCare, which includes the Massachusetts General Hospital, the Brigham and Women's Hospital, McLean Hospital and Spaulding Rehabilitation Hospital, he dealt with all the corporate issues related to support of their unique biomedical research programs, comprising $900M/year in aggregate. He holds faculty appointments in the Harvard-MIT Division of Health Sciences and Technology (HST) and in the Harvard Medical School, and his academic activities include work on development of minimally invasive technologies, and on implementation of new systems technologies in the healthcare system. His past work includes leading the Bioengineering group at MGH which conducted pioneering studies, 30 years ago, of human error in medical care. Research concepts of his have led to the development of several high-technology physiologic-monitoring products used worldwide in anesthesia and intensive care.
With a Bachelors degree from MIT, he holds a Ph.D. from Harvard University in solid-state physics. Honors include the Arnold O. Beckman Award for Innovation from the Instrument Society of America, The AAMI Becton-Dickenson Career Achievement Award, election as Sr. Member in IEEE, and election as a Fellow in the American Institute of Medical and Biological Engineering.
Randolph Noelle, Ph.D.
Dr. Randolph Noelle, Ph.D., is a Professor in the Department of Microbiology and Immunology, Director of the Immunology Program of the Norris Cotton Cancer Center and an adjunct member of the Department of Biochemistry.
In 1984, he joined the faculty at Dartmouth Medical School. In 1991, Dr. Noelle's laboratory identified a novel membrane protein expressed on helper T lymphocytes (Th), CD154. This ligand, and its receptor, CD40 play a central role in regulating the development of both humoral and cell-mediated immunity. Currently, five areas of active investigation are underway in relation to this ligand-receptor pair: 1) the molecular basis for CD40 signaling, 2) the role of this and other immune mediators in inflammation in the central nervous system, 3) regulation and development of B cell memory and plasma cells, 4) the role of CD154 in immune tolerance to transplanted tissues and organs, and 5) the translational development of CD154 for the treatment of autoimmunity and graft rejection.
Dr. Noelle received his Ph.D. from Albany Medical College 1980, and was a Post-doctoral Fellow at the University of Texas Health Science Center at Dallas from 1980-84.
Keith D. Paulsen, Ph.D.
Dr. Keith D. Paulsen, Ph.D., is the Robert A. Pritzker Chair in Biomedical Engineering at the Thayer School of Engineering at Dartmouth, Professor of Radiology at Dartmouth Medical School, Director of the Advanced Imaging Center at Dartmouth-Hitchcock Medical Center and Co-Director of the Cancer Imaging and Radiobiology Research Program at the Norris Cotton Cancer Center. He is an Associate Editor of the IEEE Transactions on Medical Imaging. His research specializes in cancer imaging techniques in the breast and brain. Dr Paulsen has published over 200 articles in the peer-reviewed scientific and medical literature and has received numerous awards for funding his research from the National Institutes of Health.
He has maintained an active research program with funding from the NIH for more than twenty years that is currently focused on the development and evaluation of imaging methods for diagnostic and therapeutic clinical decision-making in the identification and management of cancers, primarily of the breast and brain. Dr Paulsen served as a member of the Radiation Research Study Section from 1996-2000 and the Biomedical Imaging Technology Study Section from 2002-2006 within the Center for Scientific Review at the NIH. He has published more than 200 peer-reviewed journal articles in medical engineering, physics and clinical literature.
Dr. Paulsen received the B.S. degree in Biomedical Engineering from Duke University in 1981 and the M.S. and Ph.D. degrees in 1984 and 1986, respectively, from Dartmouth where he studied advanced computational methods for biomedical modeling of cancer treatments. He was an Assistant Professor in the Department of Electrical Engineering with a joint appointment in Radiation Oncology in the Health Sciences Center at the University of Arizona from 1986 to 1988. Dr. Paulsen returned to Dartmouth where he became an Associate and then Full Professor of Engineering Sciences in 1994 and 2000, respectively.
Roderic I. Pettigrew, M.D., Ph.D.
Roderic Pettigrew, M.D., Ph.D., is the first director of the National Institute of Biomedical Imaging and Bioengineering. Prior to his appointment, he was a Professor of Radiology Medicine (Cardiology) at Emory University, as well as Professor of Bioengineering at the Georgia Institute of Technology. He also served as Director of the Emory Center for Magnetic Resonance (MR) Research at Emory University School of Medicine in Atlanta, Georgia.
Dr. Pettigrew is known for his pioneering research at Emory University involving four-dimensional imaging of the heart using MR. He graduated cum laude with a B.S. in Physics from Morehouse College where he was a Merrill Scholar. He received an M.S. in Nuclear Science and Engineering from Rensselaer Polytechnic Institute, and he received a Ph.D. in Applied Radiation Physics from the Massachusetts Institute of Technology as a Whitaker Harvard-MIT Health Sciences Scholar. Subsequently, he received an M.D. from the University of Miami School of Medicine in an accelerated two-year program, served an internship and residency in Internal Medicine at Emory University, and completed his residency in Nuclear Medicine at the University of California, San Diego. Dr. Pettigrew then spent a year as a Clinical Research Scientist with Picker International, the first manufacturer of MR equipment. In 1985, he joined Emory as a Robert Wood Johnson Foundation Fellow focusing in non-invasive cardiac imaging.
Dr. Pettigrew's awards include membership in Phi Beta Kappa, the Bennie Award (Benjamin E. Mays) for Achievement, and he was named the Most Distinguished Alumnus of the University of Miami. In 1989, when the Radiological Society of North America met to celebrate its 75th (Diamond) Anniversary, Dr. Pettigrew was selected to give the keynote Eugene P. Pendergrass New Horizons Lecture. He has served as Chairman of the Diagnostic Radiology Study Section for the Center for Scientific Review at NIH, and has been elected to membership in the Institute of Medicine and fellowships in the American Heart Association, the American College of Cardiology, the American Institute for Medical and Biological Engineering, the International Society for Magnetic Resonance in Medicine, and the Biomedical Engineering Society.
Brian W. Pogue, Ph.D.
Brian W. Pogue, Ph.D., is Dean of Graduate Studies at Dartmouth College and a Professor of Engineering Sciences at the Thayer School of Engineering at Dartmouth. He holds a Research Scientist appointment through the Wellman Center for Photomedicine at the Massachusetts General Hospital, and has published over 300 papers and abstracts in the areas of biomedical optics, diffuse spectral tomography, breast cancer and photodynamic therapy of cancer. His research focuses on applications of biomedical optics in imaging and treatment of cancer. The work is funded through two program grants and several individual grants from the National Cancer Institute.
He is Deputy Editor for the journal Optics Letters for the OSA. He is also on the editorial boards of Medical Physics, the Journal of Biomedical Optics, and the Journal of Photochemistry and Photobiology B, and is a Program Chair for the upcoming European Conference on Biomedical Optics, in June 2009 in Munich.
Dr. Pogue graduated with B.Sc. Honors and M.Sc degrees in Physics from York University in Canada, and a Ph.D. in Medical Physics from McMaster University, in Canada. Following this he became a Research Fellow at the Harvard Medical School in the Wellman Center for Photomedicine.
At Dartmouth Dr. Pogue teaches classes in Medical Imaging, Electrical Engineering and the Ph.D. Professional Workshops, training graduating doctoral students about how to prepare for life after graduation in academia and industry.
Peter J. Robbie, M.F.A.
Peter J. Robbie, M.F.A., is a product designer, Associate Professor of Engineering and Lecturer in the Department of Engineering Sciences at Dartmouth.
Robbie's research focus is medical imaging and treatment planning. He was a co-founder of Medical Media Systems (MMS) where he was senior vice president for product design and clinical affairs. MMS (now M2S) is an industry leader in cutting-edge imaging technology for treatment planning. The MMS team designed and developed an advanced imaging system, Preview Treatment Planning Software, which received FDA and HICFA approvals for advanced minimally invasive procedures such as endovascular repair of aortic aneurysms. Recently he has been a consultant on the design team for the MIST Project, a microwave imaging system for detection of breast cancer.
At Dartmouth Robbie teaches product design, creative problem solving, and design for human use. He received an M.F.A. from Cornell University (1972) and for several years taught three-dimensional design in the Visual Studies program at Dartmouth. He is a professional member of the Industrial Design Society of America (IDSA) and has served as a design consultant for several corporations.
Michael J. Ross, Ph.D.
Michael J. Ross, Ph.D., is a general partner at SV Life Sciences, an international venture capital fund focused exclusively in the life sciences, and is the US partner leading the therapeutics team. Mike graduated from his A.B. degree at Dartmouth in 1971 and completed his Ph.D. at the California Institute of Technology. Prior to joining SV Life Sciences, Michael was the tenth employee at Genentech where he worked for 13 years. He served as Genentech team leader for Humulin® (human insulin-Lilly), Roferon® (Interferon alpha -Roche), Protropin® (hGH), and as Vice President of Development during the development of Activase®, Nutropin® and Pulmozyme®. Michael then started Genentech's protein engineering and small molecule discovery effort as Vice President of Medicinal and Biomolecular Chemistry. Michael was the Founding CEO of Arris Pharmaceutical (now part of Celera), MetaXen (now part of Exelixis), ExSAR and CyThera (now part of Novocell). Michael was most recently Managing Partner in Didyma, LLC, a biotechnology management consulting firm.
Julie A. Shimer, Ph.D.
Julie A. Shimer, Ph.D., is President & CEO of Welch Allyn, a leading global manufacturer of medical diagnostic equipment and a complete range of digital and connected solutions. She worked at AT&T Bell labs from 1982 to 1992, staring as a member of the technical staff, and ending up as the Department Head for VLSI Process Development. From 1993 to 2000 she worked at Motorola Inc. as Vice President and General Manager for several divisions. From 2001 to 2007 she was President and CEO of Vocera Communications, prior to her current position at Welch Allyn. She is a Senior Member of the IEEE and Society of Women Engineers; member of Sigma Xi, on the Board of Directors of the Engineering Information Foundation, and the Consumer Electronics Association. She sits on the National Medal of Technology Nomination Evaluation Committee, as well as the Motorola Scientific Advisory Board
She completed her B.S. in Physics at the Rensselaer Polytechnic Institute, followed by M.S. and Ph.D. degrees at Lehigh University in Electrical Engineering.
Robert Sprinkle, M.D., Ph.D.
Robert Sprinkle, M.D., Ph.D., is a physician and policy scholar. He studied history at Dartmouth College and medicine at the University of Cincinnati. He trained clinically at the University of Virginia and the University of Texas Southwestern Medical Center, Dallas, and is a diplomate of both the American Board of Family Medicine and the American Board of Pediatrics and a Fellow of the respective academies. In Dallas he served three years as a family-medicine residency-program director and as an attending physician in three disciplines. He moved to the Woodrow Wilson School of Public and International Affairs, Princeton University, to earn a second doctorate, the Ph.D. While enrolled at the Wilson School, he was for two years a Social Science Research Council MacArthur Foundation Fellow in International Peace and Security and for two months a refugee-camp physician. Subsequently, at Duke University, he held clinical, policy-studies, and applied-ethics positions and staffed federal clinical-practice guideline panels for sickle cell disease and unstable angina. He was recruited to the University of Maryland School of Public Policy in 1995 and was promoted to a tenured associate professorship in 2001. At Maryland he has created and taught graduate and honors-undergraduate courses across the full range of his policy interests. He is the author or coauthor of papers in clinical medicine, bioethics, health policy, bioengineering, environmental policy, political philosophy, international relations, and biosecurity. He is the author of the book, Profession of Conscience: The Making and Meaning of Life-Sciences Liberalism (Princeton University Press, 1994), an intellectual history of political-ethical thought in the life sciences. He was Editor-in-Chief of Politics and the Life Sciences for two terms, from 2001 through 2007; in 2008 he became Contributing Editor for Electronic Publishing. He spent the 2007-2008 academic year on sabbatical at Dartmouth, where he held visiting positions in Ethics, in Public Policy, and in Pediatrics.
Anna N.A. Tosteson, Sc.D.
Anna Tosteson, Sc.D., is a Professor of Medicine and of Community and Family Medicine at Dartmouth Medical School, Associate Director for Dartmouth's Multidisciplinary Clinical Research Center in Musculoskeletal Diseases, and a faculty member of The Dartmouth Institute for Health Policy and Clinical Practice. She did her undergraduate studies at Cornell and her graduate studies at Harvard, where she studied biostatistics and health decision science. Her research uses decision-analytic modeling, economic evaluation and preference-based measures of health-related quality of life to address clinical and health policy issues in osteoporosis/musculoskeletal diseases and women's health. She is an active participant in national and international groups that focus on the economic evaluation of both new and established health care technologies including the American College of Radiology Imaging Network. She teaches in The Dartmouth Institute for Health Policy and Clinical Practice's degree programs.
Milton C. Weinstein, Ph.D.
Milton C. Weinstein, Ph.D., is the Henry J. Kaiser Professor of Health Policy and Management at the Harvard School of Public Health and Professor of Medicine at the Harvard Medical School. At the Harvard School of Public Health he is Academic Director of the Program in Health Decision Science, and Director of the Program on Economic Evaluation of Medical Technology. He is currently also Visiting Professor in the Department of Economics and Visiting Scholar in The Dartmouth Institute for Health Policy and Clinical Practice. He is best known for his research on cost-effectiveness of medical practices and for developing methods of economic evaluation and decision analysis in health care. He is a co-developer of the CEPAC (Cost-Effectiveness of Preventing AIDS Complications) computer simulation model, and has conducted studies on prevention and treatment of HIV infections. He is the co-developer of the Coronary Heart Disease Policy Model, which has been used to evaluate the cost-effectiveness of cardiovascular prevention and treatment. He is an author of four books: Decision Making in Health and Medicine: Integrating Evidence and Values; Cost-Effectiveness in Health and Medicine, the report of the Panel of Cost Effectiveness in Health and Medicine; Clinical Decision Analysis; and Hypertension: A Policy Perspective. He has also published more than 200 papers in peer-reviewed medical, public health, and economics journals. He is an elected member of the Institute of Medicine of the National Academy of Sciences, and a recipient of the Award for Career Achievement from the Society for Medical Decision Making. Dr. Weinstein received his A.B. and A.M. in Applied Mathematics (1970), his M.P.P. (1972), and his Ph.D. in Public Policy (1973) from Harvard University.
Michael Zubkoff
Michael Zubkoff is Professor and Chair of the Department of Community and Family Medicine at Dartmouth Medical School, Professor of Economics and Management at the Tuck School of Business at Dartmouth, and Director of the MD-MBA Program at Dartmouth.
The faculty of the Department of Community and Family Medicine, which he has chaired since 1975, have the largest sponsored research budget of any such department in the nation (annual budget of over $35 million - direct costs only), and were cited by the U.S. Liaison Committee on Medical Education for their "excellence in academic pursuits and community-based teaching ... made all the more prominent by their wide ranging nationally recognized research programs." Professor Zubkoff was elected to membership in the National Academy of Sciences' Institute of Medicine in 1983, and has been profiled in Who's Who in America each year since 1976. He has been the recipient of two honorary degrees and has served on the board of directors of a number of foundations and corporations. For the past 23 years he has served as a correspondent for the Committee on Human Rights of the National Academy of Sciences.
After completing his training and studies at Columbia University Professor Zubkoff served, from 1967-1975, as Vice Chairman of the Department of Family and Community Health at Meharry Medical College, and Assistant/Associate Professor of Economics and Director of the Health Services Research Training Programs (Ph.D. and Masters) at Vanderbilt University, in Nashville, Tennessee. During 1967-1969 he also taught at Fisk University under the Woodrow Wilson Fellowship Foundation's Teaching Fellows Program. Throughout this period he served in a number of positions (including President, Vice President and Treasurer) within the Medical Committee for Human Rights' southern branch which among it's many initiatives coordinated medical coverage at the Civil Rights Marches being led by Dr. Martin Luther King, Jr., throughout the south.
In 1974, Professor Zubkoff was asked by President Ford to serve as rapporteur for the Department of Health, Education and Welfare (HEW) PreSumit Conference on Inflation in Health Care, and to personally present the HEWs PreSumit Conference recommendations to President Ford, his economic advisors, leaders of congress and delegates, during the nationally televised White House Summit on Inflation. He has served as an advisor and/or consultant to the White House staffs of Presidents' Ford, Carter, Reagan, Bush, Clinton and Bush, leaders of the U.S. House and Senate and corporate executives throughout the world.
During the late 1980's Professor Zubkoff was co-founder together with Drs. Tarlov, Ware, Greenfield, Nelson, and Perrin of the Medical Outcomes Study (MOS) based at RAND Corp, and has served since then as a member of the MOS Steering Committee, which oversees and monitors all analyses and publications. He was recipient of the Association for Health Services Research (AHSR) 1993 Article of the Year Award for two of the Medical Outcomes Study articles he co-authored on "Variations in Resource Utilization Among Medical Specialties and Systems of Care" and "Differences in the Mix of Patients Among Medical Specialties and Systems of Care," which appeared in the Journal of the American Medical Association.
Professor Zubkoff currently directs the Dartmouth MD-MBA Program, teaches courses on Medical Care Organization, Economics and Management in the Amos Tuck School of Business Administration's MBA Program and Dartmouth's Center for the Evaluative Clinical Sciences' MPH, M.S. & Ph.D. Programs, and co-directs the 4th year required medical student course Health, Society and the Physician, and was recently asked to serve as a member of the National Academy of Sciences/Institute of Medicine/National Research Council's Board on Children, Youth and Families.


text:
Image-Line Software are pleased to announce the FL Studio 9.9 Beta is available for testing. You can find the download links here.
After downloading don't forget to check for updates in the FL Studio 9.9 Beta forum. Please note, all previous FL Studio 9.x Betas have expired and you need to download the 9.9 Beta to continue work started in earlier versions. FL Studio 9.9 expires April 15.
What's New?
The Project Picker improves Playlist workflow allowing Patterns to be previewed and selected
Chainer is an instrument and effect plugin Patcher
ZgeViz is a music visualization effect plugin based on the free open source ZGameEditor
Other changes relate to bug-fixes and can be seen here. Please report any bugs to the FL Studio 9.9 Beta forum, if you don't report them we can't squash'em :)


text:
Offshore Umbrella Services
Offshore Umbrella Services, or Fiduciary Factoring is an easy and quick Tax Planning solution to achieve offshore wealth without any taxation. You will receive 90% of your expatriate income & funds tax-free.
International Banking
Expert Expat is offering its long experience in international bank services, with a lot of advantages such as easiness of use and low cost. It is also a strategic choice for your patrimony and your taxation plans.
Health Insurance
We act as an independent international medical, health and travel insurance broker. In partnership with companies specialised in expatriate insurance, we offer you the best deals on the market.


text:
FutureAngels.com Radio — Episode 6
The latest episode of FutureAngels.com Radio is now on-line. You can get to the link through the home page at www.futureangels.com.
This episode features:
- A look back at Gene Autry Park, the Angels former minor league complex.
- An interview with Tony Reagins, the Angels' Director of Player Development.
- A talk with Matt Hurst, the Angels beat writer for the Riverside Press-Enterprise.
You need Windows Media Player to listen. You can either stream the audio or download it to your MP3-compatible device.


text:
|Mobile Site
|eMail Author
|Caption Comp
|Monthly Poll
|Sudden Death
|Colour Key
|Cookie Usage
|Series :
|Rating :
|Disc No :
|Episode :
|First Aired :
|21 Jan 2004
|Stardate :
|Director :
|David Livingston
|Year :
|Writers :
|Chris Black
|Season :
|Guest Cast :
|Not necessarily a nit, but the Xindi prototype seems awfully small. This thing fitted into Shran's ship, and was expected to fit into Enterprise's launch bay. Yet the full weapon we saw in Twilight was huge, much larger than the Xindi ships accompanying it. Isn't a prototype supposed to be a close match to the final product?
|Great Moment :
|Shran's antennae appearing over Archer's head, a laugh-out-loud moment!
|Body Count :
|One Enterprise crewman falls off a catwalk when they hit the anomaly, level of injury unknown; otherwise none.
|Factoid :
|Andorian antennae are remote controlled; the actors have a small unit under the hair on the back of their heads, and two people stand off-screen to move them around.
This is the first episode to show us the inside of an Andorian ship.
There's nothing terribly new or original here. The Xindi weapon arc is trundling along after a couple of episodes where it receeded into the background. The double cross itself was pretty obvious, but then the episode didn't really make a big deal of trying to trick the audience here, showing us Shran's orders in advance. It's nice to see that Archer also anticipated it and had good a counter-plan ready to go.
It's becoming obvious that there is a system governing the behaviour of the Andorian antennae. Normally they point straight up and slightly to the sides. When an Andorian is really interested in something or someone they point towards that thing or person. When they are angry the antennae fold back almost flat against the skull; the latter is presumably so that they are less likely to be damaged in any fighting.
|Copyright Graham Kennedy
|Page views : 22,707
|Last updated : 23 Nov 2014


text:
Tigers Stopped at Home by Racers
NASHVILLE, Tenn. – Tennessee State dropped both ends of a double header to Murray State on Saturday afternoon at Tiger Field. The Racers grabbed the wins by the scores of 3-0 and 8-1. The Tigers fall to 1-3 in Ohio Valley Conference play and 13-19 on the season, while MSU improved to 2-2 in the OVC, 13-13 overall.
TSU was held to one run and seven hits on the day. The Racers received a five-hit shut by CheyAnne Gaskey (6-7) and a two-hit, one-run, six inning performance by Mason Robinson (5-4).
The Tigers threatened in the first inning of game one. Lindsey Burgess reached on a walk and moved to second on a sacrifice bunt by Courtney Gearlds, who reached on an error. Ashley Haynes followed two batters later with a single through the right side of the infield to load the bases. Gaskey would get out of the inning as she induced Jayna Hanawahine to hit into a double play.
The Tigers managed to get base runners on over the next two innings, a Kiarra Freeman two-out single in the second and a lead-off single by Burgess in the third, but could not push a run across. The trend continued in the fourth as TSU stranded two more runners by not taking advantage of a one-out double by Rebekka Gross and a second base runner, as Tayler Shimizu reached on an error.
Murray State put a pair of hits together in the top of the fifth as the put a run on the scoreboard against TSU starter, Hannah St. Clair. The freshman was tagged with the loss and is now 2-6 as she scattered seven hits and two walks, allowing two runs, one earned.
MSU added two unearned runs in the seventh as they claimed the 3-0 win.
In game two, MSU scratched a run in the first inning without recording a hit off starter Olivia Gamache. The Tigers responded in the bottom of the second as they loaded the bases on walks to Kate Morris and Gross, and a single by Hanawahine. Shimizu came through with an infield single to plate Morris, but Gross was thrown out at home on the play.
Robinson would settle in and go on to retire the next 12 Tigers. Burgess reached base on a hit by a pitch, to break the string of batters sat down by Robinson. But it was to no avail as MSU would get the next four Tigers in order.
The Racers secured the win with a run in the third, five in the sixth and another in the seventh.
Gamache fell to 4-7 as she was touched for five runs, three earned, on six hits and five walks. The senior hurler notched four strikeouts and moved into fourth on the TSU career list, by passing Candace Hildebrand (2006-07).
TSU hits the road for a twin bill at Austin Peay on Sunday. First pitch is scheduled for 12:00 pm and can be heard on tsutigers.com.


text:
Whitewater Mennonite Church Group (Manitoba, Canada)
The Whitewater Mennonite Church was organized on 18 April 1927 by Mennonite families from the Soviet Union who settled in that community in 1924. The first elder was Franz F. Enns of Lena, Manitoba, who had been elder of the Terek Mennonite Church. On 16 June 1938 Gerhard G. Neufeld (1902-1997) succeeded him.
In 1931 the church had six congregations led by Elder Franz F. Enns and assisted by 14 ministers. The church had 452 congregational members, a total of 964 members and adherents, and 187 families.
In 1958 the congregation had 565 members and a total population of 1,209 persons in 257 families. It had six congregations at that time: Whitewater (162 members), Rivers (96 members), Ninga (63 members), Lena (80 members), Crystal City (135 members), Manitou (29 members). Five of these groups had their own meetinghouses. In 1958 all worship was in German.
The Elder performed all baptisms and observed the Lord's Supper four times annually with all congregations. Footwashing was practiced at one time, but was dropped.
The Whitewater group of congregations merged into the Conference of Mennonites in Manitoba in 1947.
Ens, Anna. In Search of Unity: Story of the Conference of Mennonites in Manitoba. Winnipeg, MB: CMBC Publications, 1996.
Konferenz-Bericht der 26. Konferenz der Mennoniten im mittleren Canada, abgehalten in Rosthern, Sask., den 2., 3. end 4. Juli 1928.
Neufeld, G. G. Die Geschichte der Whitewater Mennoniten Gemeinde in Manitoba, Canada 1925-1965. Altona, MB: D.W. Friesen, 1967.
|G. G. Neufeld
|Richard D. Thiessen
|Date Published
|May 2012
Cite This Article
MLA style
Neufeld, G. G. and Richard D. Thiessen. "Whitewater Mennonite Church Group (Manitoba, Canada)." Global Anabaptist Mennonite Encyclopedia Online. May 2012. Web. 24 Feb 2020. https://gameo.org/index.php?title=Whitewater_Mennonite_Church_Group_(Manitoba,_Canada)&oldid=130772.
APA style
Neufeld, G. G. and Richard D. Thiessen. (May 2012). Whitewater Mennonite Church Group (Manitoba, Canada). Global Anabaptist Mennonite Encyclopedia Online. Retrieved 24 February 2020, from https://gameo.org/index.php?title=Whitewater_Mennonite_Church_Group_(Manitoba,_Canada)&oldid=130772.
Adapted by permission of Herald Press, Harrisonburg, Virginia, from Mennonite Encyclopedia, Vol. 4, p. 940. All rights reserved.
©1996-2020 by the Global Anabaptist Mennonite Encyclopedia Online. All rights reserved.


text:
On 'Mad Men,' coming a long way, and going away forever
You were only a bird in a gilded cage
A beautiful sight to view
So dainty and delicate you seemed
No rights would they give to you
When you said you should vote
and you said you should smoke
The men were all in a rage
The way of the world said you should remain
a bird in a gilded cage
You've come a long way baby
To get where you've got to today
You've got Virginia Slims now baby
You've come a long, long way
—Virginia Slims jingle, 1968-1971
This whole season of "Mad Men" seemed to be about coming so far that you circle back to where you started. It's easy to lose your way in a house of mirrors, with your reflection always shining back at you.
Megan was the secretary-turned-wife who turned out to be accidentally good at being more. Copywriting came easily to her and so she grew bored and wanted to try her hand at something where she'd have less control. As an actor, you're at the mercy of other people. She also craves the drama. Don and she are united in this, just like when they sold the idea of magic beans to the client. Now that she isn't getting that drama professionally, through roles in plays, she seeks it out in her home life. She gets drunk and puts on a show.
"Please, it's the only thing I'm good for," she tells Don when he can't kiss her because of his rotting abscess. "This is what you want for me to be, waiting for you at home. It's either that or I'm terrible."
In season one, a rival agency asks Betty to do a Coke ad, but it's just a way for them to try to woo Don. Don lets it happen in order to protect her feelings but it's not like he takes her work seriously. If anything, it's an embarrassing reminder of the kind of man he is, one who is married to a former model with a need to see her fleeting beauty captured on film. He's always loved Megan most—and we have too—when she was going against type. He first proposed to her when she acted like a proper mother to his kids, but he himself is most turned on by her when she's taking charge. He is enamored of genuine talent, so when he told her not to quit the agency it was as much about how it pained him to see her talent as a copywriter go to waste as it was about wanting to keep her under his thumb. He wanted Megan to be both his "discovery" and his wife.
At SCDP, Megan felt compelled to prove her own worth separate from Don but she never felt entirely committed to the role of the modern career woman. It was so much more relaxing to regress, to giggle dreamily while her strapping husband fixed the sink. And now that she's away from the judgmental eyes of progressive women like Peggy, she's free to return full circle back to the role of trophy wife. She's never much cared about how it might look when it came to her needs. "Ken, Stan and Ginsburg will be there," Don tells her after she asks him to submit her screen test for an ad campaign SCDP is working on. "They know you."
Peggy meanwhile is about to make a name for herself selling the same product that her mentor Don swore off in his one of his great shining moments. At SCDP, Peggy bristled at being assigned women-only products; she told Roger she could sell wine to the Jews with the best of them. But she doesn't seem to mind now that she's on top, coming up with a top-to-bottom campaign for a cigarette marketed to women, a product that amazingly hadn't already been developed in 1967. But no matter how much fun it is stay in a hotel, won't the allure of selling a product "for which the work is irrelevant because people can't stop themselves from buying it" wear off? She came her long, long way in order to head up a campaign whose gist is that women are so much mens' equals that they have the right to poison themselves same as they do.
Some people may have found the Don and Peggy movie-theater scene cozy, but to me it rang false. One of my favorite moments in the whole series was when Peggy said goodbye, and it crushed me a little to watch a much weaker scene come on the heels of that. Their running into each other felt oddly rom-com, and the money line—"That's what happens when you help someone; they succeed and move on"—would've been better left unsaid. It had already been floating under these last two episodes anyway. It was the undercurrent to Don's coldness with Lane and the reason the bags under Don's eyes have grown so heavy and dark.
"You really do have the same eyes," says the nurse about Pete and Rory Gilmore. When they first met, Rory told him that his eyes were the color of earth, but now they're more the shade of the apocalypse, as blank and ravaged as hers. Again, I had problems buying this scene, even though I looked up electroshock treatment and it does erase the memories of the distant past.
I prefer when "Mad Men" has the texture of a short story, not when it tries outright to read like one. (Also I'm sorry, Rory, but I wish you were being played by a different girl. You seem to be the only one on this show whose acting role-model is January Jones.) It's an enviable position, though, the one she is in, the ability to wipe one's mind of the bad memories. Pete says it's just for people who can't solve problems, but are the shock treatments really so different from the dose of world-blocking-out noise he administers to himself every night with his hi-fi and headphones?
Pete tells Rory his "friend" is sick, but everyone on this show is. They're all desperate to take the right medicine. Megan's getting drunk, Roger's dropping acid and Don is breathing in the dentist's ether. He's visited from the Ghost of Season One, back when his double life was the main motor propelling the show: his brother Adam. Don has kept secrets his entire life and so it's no surprise that he's able to keep the reason behind Lane's death from the rest of the firm. The only evidence of his involvement is, again, those bags under his eyes and that tooth, the pain of which he thought would just go away if he ignored it. Lane's wife tells him it may be the difference between cultures that she isn't one to wallow, but Don is no stranger to repression. Lane came from a galaxy far, far away called England and when he was told it was his turn to return to the home land, he chose an alternative route.
Joan did too, in her quest to get where she is. She either took a short cut or the longest route ever, depending on how you look at it. After decades of sitting at her desk, she now can't stop climbing higher and higher. The firm is expanding toward the sky while the spirits of the rest of the staff are sinking. Joan makes an X where the staircase will go and Pete says he will finally have a view like Don's. In the same way that women have earned the right to die of lung cancer too, Pete has fought hard to be able to replicate his hero's mistakes. He's become a tiny figment of a landscaper's rendering, sitting by the pool while Don is inching closer, as the agency floor number grows bigger; he is on his way to becoming the falling man in the opening credits (even though I think we're done with death on this show for awhile.)
Dawn the secretary came a long way only to be relegated (disappointingly so) to a character who feels more invisible than if she hadn't been written in at all. Ginsburg looks like he's going to be the focus of next season, since he's the only one with enthusiasm for the job. "It's a great thing to take advantage of hopeless people."
He's come such a long way in such a short time that he's grown disillusioned with Don twice as quickly as it took everyone else to.
Sally spent the season racing along the path toward adulthood and then, the moment she arrived at it, turned on her heels and tried to regain being a kid.
Maybe the only way forward is out the door. If you stay in the room too long, the ideas get stale, the clients get pissy, the liquor cabinet gets emptied out. Megan's mum has a rendezvous with Roger. She defies his expectations by showing him that a real woman both abandons her grown daughter and refuses to parent a grown man. Don begs his dream-sequence brother not to leave him but then he runs into Peggy coincidentally at the movies. She hasn't strayed as far as he thought but it's so hard to tell what is real anymore.
Megan wants his help being the officially sanctioned beauty to his beast, but he's made it clear how that always turns out. They succeed and move on. So why does he do it? Partly out of love, I'm sure. He even has faith in her. If any one believes in the selling power of a Super 8 film, it's Don. It happened in the Kodak carousel episode in season one, and maybe that memory is in Don's mind as he watches Megan's screen test now: how good at everything he once was.
It could be argued that he helped her as a means of being able to keep her, set a gilded bird free and all that. To me, though, the moment Megan presented herself to Don to as just another pretty girl in a commercial, instead of the woman who wants to write the lines for some other random girl to say, she lost some of her luster to him.
That relief he talked of to Lane about is also in the quitting-tobacco letter he wrote seasons ago. "Recently my advertising agency ended a long relationship with Lucky Strike cigarettes and I'm relieved." He "realized here was my chance to sleep at night" instead of selling "a product that never improves, that causes illness, and makes people unhappy…. We knew it wasn't good for us but we couldn't stop."
Megan and Don's marriage has had its moments of peace but they've been embedded inside just as many days filled with aching teeth, murderous fevers, smashed bowls of pasta, screeching car wheels and sleepless nights. Don's great fear of abandonment could also be his ticket out. That last scene in the bar, where he's looking like the cat who ate the bird, certainly indicated that he had escape on his mind.
"I suddenly feel this door open and I want to walk through it," says Rory to Pete, and then, "I should go."
"Because it works."
Starlee Kine is a a frequent contributor to PRI's "This American Life." She has written The Girl, a weekly look at "Mad Men," every Monday this season. Previously: On 'Mad Men,' pain, pride and violence outlast enlightenment.
Find all of her writing on 'Mad Men' here.
Photos by Michael Yarish/AMC.


text:
The LX4000 Computerized Polygraph System records, stores, and analyzes physiological changes during a polygraph examination. The LX4000 system combines conventional polygraph procedure with sophisticated state of the art technology. Results are derived from the following traditional physiological parameters:
Pneumo - Two Respiration Input Channels
EDA - Galvanic Skin Response
Cardio - Blood Volume / Pulse Rate
We currently offer a Plethysmograph (PPG) Model 76604A-5L with an adaptor (Model 76604ADP) to measure finger pulse and blood volume, Activity Sensor Model 76879S to measure any movement by the subject to help identify countermeasures. A total of seven channels can be recorded at one time.
Charts are recorded in much the same manner as conventional polygraph instrumentation with a smooth scrolling display moving from right to left. The tracings recorded are in real-time and are truly rectilinear, so charts can be easily interpreted. See polygraph software page for a sample of the tracings. The system can be operated using a mouse / pointing device or the keyboard.


text:
"Emily demystifies meditation in a real and practical way that anyone can understand. She makes incredibly complex knowledge seem so accessible."
"I have just done the visualization for my presentation tomorrow. I trained in hypnosis as well, but I can say with certainty that Emily's visualization guidance stands out—it is simply the best one I have ever seen!"
"I used to have have terrible stage fright. Since learning meditation with Emily everything shifted. I rarely have performance anxiety. Even performing live for millions of people, I'm not nervous anymore."
"Honestly I wouldn't be where I am now, or rocketing forward, if it weren't for Emily...Emily's instruction and shine has made the journey an incredible one and I wouldn't trade her or the practice for the world."
How It Works
You'll have unlimited access to hours of meditations, all from the comfort of your own home. Lifetime access to the class allows you to return to the videos whenever you may need to destress, get focused, or find a little peace of mind.
You'll take what you've learned in the videos and put it into practice. Return to any session as often as you'd like, or use what you've learned and apply it on your own.
Interactive discussion boards allow you to discuss what's on your mind with instructors and fellow students. Get your questions answered, while joining a community of other wellness enthusiasts.
Find your happiest, healthiest self.
Our classes are designed to give you a simple and effective educational experience so you can focus on "you". Whether you're at home or on the go, you'll have access to world-class experts and a thriving community of wellness enthusiasts - all here to help you along the way.
Classes FAQS
All you need is WiFi or a direct internet connection - no downloads or DVDs required! All classes stream directly to the device of your choosing.
Whenever you're ready! There's no set start (or end) date here.
Learn at your own pace. Some classes have a suggested timeline, but you are free to adjust to fit your own schedule.
Yes! Watch as much as you'd like, and for as long as you'd like. Once you've completed the class, it's yours to keep!
No problem - let us know and we will work with you personally to find another class that suits you better.
We really hope you love it! Unfortunately, we're not able to offer refunds for the programs. If you're on the fence, we strongly recommend that you watch the preview videos to get a sense of what the class is like before you buy.
Email us at email@example.com. We're happy to answer all of your questions.


text:
DEV540: Secure DevOps and Cloud Application Security New
Sun, September 23 - Thu, September 27, 2018
DEV540 gives developers and security professionals the tools needed to build and deliver secure software using DevOps and cloud services, specifically Amazon Web Services (AWS). It explains how the principles, practices, and tools of DevOps and AWS can improve the reliability, integrity, and security of applications.
The first two days of the course examine the implementation of Secure DevOps using lessons from successful DevOps security programs. Using popular open-source tools such as GitLab, Puppet, Jenkins, Vault, Graphana, and Docker, you will create a secure DevOps CI/CD toolchain that can automatically build, test, and deploy infrastructure and applications. In a series of labs, you will inject security into your CI/CD toolchain using a variety of security tools, patterns, and techniques.
The final three days of the course will teach you to shift your DevOps workloads to the cloud and secure software using AWS. With your CI/CD toolchain, you will build a cloud infrastructure that can deploy applications and microservices to the cloud, instead of to local servers. You'll also analyze and fix cloud infrastructure and application vulnerabilities using AWS security services and tools such as API Gateway, IAM, CloudFront Signed URLs, Security Token Service, KMS, encryption, WAF, Lambda for Serverless computing, CFN NAG scanner, AWS Security Benchmark, and much more.
DEV540 makes extensive use of open-source materials and tooling for automated configuration management ("Infrastructure as Code"xf), Continuous Integration, Continuous Delivery, Continuous Deployment, containerization, micro-segmentation, automated compliance ("Compliance as Code"), and Continuous Monitoring. It also uses Jenkins and AWS developer tools such as CloudFormation, CodeCommit, CodeBuild, CodePipeline, and other cloud application services, so you can experience the use of these services when securing infrastructure and applications.
DEV540 will prepare you to:
Understand the core principles and patterns behind DevOps:
- Recognize how work is done in DevOps and identify keys to success
- Map and implement a Continuous Delivery/Deployment pipeline:
- Create a Value Stream Map of the processes and workflows to make code or configuration changes, from check-in to deployment and operations
- Utilize Continuous Integration, Continuous Delivery, and Continuous Deployment workflows, patterns, and tools
- Identify the security risks and issues associated with DevOps and Continuous Delivery
- Map where security controls and checks can be added in Continuous Delivery and Continuous Deployment:
- Conduct effective risk assessments and threat modeling in a rapidly changing environment
- Design and write automated security tests and checks in CI/CD
- Understand the strengths and weaknesses of different automated testing approaches in Continuous Delivery
- Implement self-serve security services for developers
- Inventory and patch your software dependencies
- Threat model and secure your build and deployment environment
- Integrate security into production operations:
- Automate security policies
- Use container technologies (such as Docker) to enhance security
- Automate compliance and run-time defense
- Create continuous feedback loops from production to engineering
Create a plan to introduce or improve security in a DevOps environment
- Use DevOps practices to secure DevOps tools and workflows
- Move your DevOps workloads to the cloud:
- Secure your Amazon Web Services account
- Use CloudFormation to create Infrastructure as Code
- Build CI/CD pipelines using CodePipeline
- Wire security scanning into CodePipeline using CodeBuild.
- Containerize applications with EC2 Container Registry and EC2 Container Service
- Scale horizontally with load balancers and auto-scaling groups
- Consume cloud services to secure cloud applications:
- Protect sensitive secrets with KMS and the SSM Parameter Store
- Protect static content with CloudFront Signing
- Secure REST APIs with API Gateway
- Implement an API Gateway custom authorization Lambda function
- Deploy the AWS WAF and build custom WAF rules
- Monitor security events using CloudWatch
Course Syllabus
DEV540.1: Introduction to Secure DevOps
Eric Johnson
Sun Sep 23rd, 2018
The first course section introduces DevOps practices, principles, and tooling. We will examine how DevOps works, how work is done in DevOps, and the importance of culture, collaboration, and automation.
Using case studies of DevOps "Unicorns" - the Internet tech leaders who've created the DevOps DNA - we'll consider how and why these leaders succeeded, and examine the keys to their DevOps security programs.
We'll then look at Continuous Delivery, the DevOps automation engine. We'll explore how to build up a Continuous Delivery or Continuous Deployment pipeline, including how to fold or wire security controls into the CD pipeline, and how to automate security checks and tests in CD.
- Exploring CI/CD Tools and Pipelines
- Deployment Data
- Automating Static Analysis in CI
- Automating Dynamic Analysis in CI/CD
CPE/CMU Credits: 6
- Introduction to DevOps
- Case Studies on DevOps Unicorns
- Working in DevOps
- Security Challenges in DevOps
- Building a CD Pipeline
- DevOps Deployment Data
- Secure Continuous Delivery
- Security in Pre-Commit
- Security in Commit
- Security in Acceptance
DEV540.2: Moving to Production
Eric Johnson
Mon Sep 24th, 2018
Building on the ideas and frameworks developed in Section 1, and using modern automated configuration management tools like Puppet, Chef, and Ansible, you'll learn how secure Infrastructure as Code allows you to quickly and consistently deploy new infrastructure and manage configurations.
Because the automated CD pipeline is so critically important to DevOps, you'll also learn to secure the pipeline, including RASP and other run-time defense technologies.
As the infrastructure and application code moves to production, we'll spend the second half of the day exploring container security issues associated with tools such as Docker and Kubernetes, as well as how to protect secrets using Vault and how to build continuous security monitoring using Graphana, Graphite, and StatsD.
Finally, we'll discuss how to build compliance into Continuous Delivery, using the security controls and guardrails that have been built in the DevOps toolchain.
- Managing Configuration with Puppet
- Auditing Docker's Security
- Monitoring with Dashboards, Granfana, and Graphite
- Protecting Secrets with Vault
- Auditing with OpenSCAP
CPE/CMU Credits: 6
- Secure Infrastructure as Code: Building Security Policies into Infrastructure Code
- Security with Puppet Lab
- Securing Your CD Pipeline
- Threat Modeling and Locking Down Your Build and Deployment Environment
- Run-time Defense: RASP, IAST and other run-time security solutions
- Container Security: Introduction to Containers, Docker, and Docker Security Risks and Tools
- Security in Monitoring; Using Production Metrics and Insight to Drive Improvements in Your Security Program
- Red Teaming, Bug Bounties, and Blameless Postmortems
- Managing Secrets: The Problem of Secrets in an Automated Environment; Patterns and Anti-patterns for Managing Secrets
- Compliance as Code: How to Satisfy Compliance Requirements Using Continuous Delivery and Continuous Deployment
DEV540.3: Moving to the Cloud
Eric Johnson
Tue Sep 25th, 2018
Observing DevOps principles, you'll learn to deploy infrastructure, applications, and CI/CD toolchain into the cloud. This section provides an overview of Amazon Web Services (AWS) and introduces the foundational tools and practices you'll need to securely deploy your applications in the cloud.
- AWS Account Configuration and Hardening
- AWS CLI Automation
- Cloud Infrastructure Deployment with Jenkins Blue Ocean and CloudFormation
- Cloud Infrastructure Scanning and Hardening
- Security Scanning in CI/CD with CodeBuild and CodePipeline
CPE/CMU Credits: 6
Introduction to the Cloud
- Cloud Provider Comparison
- Introduction to AWS Services
- Automation with the AWS Command Line Interface
Cloud Architecture Overview
- AWS Architecture Components
- CloudFormation Infrastructure as Code
- CloudFormation Static Analysis with CFN_NAG
- Automating Cloud Architecture with Jenkins Blue Ocean
Secure Cloud Deployment
- CodeCommit Security
- Cloud Container Orchestration
- Common Cloud Security Issues such as:
- S3 Bucket Misconfiguration
- IAM Privilege Escalation
- Controlling Traffic Flow with NACLs and Security Groups
- Exposed Admin Access
- Applying Patches with Infrastructure as Code
- TLS Misconfiguration and Hardening
Security Scanning in CI/CD
- CodeBuild and CodePipeline Integrations
- Static Analysis with Serverless Functions (Lambda)
- Static Analysis with CodeBuild
- Integrating Jenkins and CodePipeline
DEV540.4: Cloud Application Security
Eric Johnson
Wed Sep 26th, 2018
In this section, you'll learn to leverage cloud application security services to ensure that applications have appropriate encryption, authentication, authorization, and access control, while also maintaining functional and high-availability systems.
- Encrypting Application Secrets with KMS and the SSM Parameter Store
- Securing CloudFront Content with Signed URLs
- Protecting REST Web Services with API Gateway
- Protecting APIs with Lambda and JSON Web Tokens (JWT)
CPE/CMU Credits: 6
Data Protection
- Data Storage (S3, RDS, DynamoDB)
- Secrets Management
- Approaches to Secrets Management
- Key Management Service
- Third-Party Solutions
Secure Content Delivery
- Introduction to Content Delivery Networks
- Restricting Origin Access with Origin Access Identities
- CloudFront Trusted Signing and Access Control with Signed Cookies and URLs
- Configuring Cross-Origin Resource Sharing Security with Bucket Policies
Microservice Security
- Microservice Architecture Attack Surface
- Microservice Security:
- Authentication with AWS Security Token Service, Identify Federation, and Web Identity Federation
- Authorization with JSON Web Tokens
- Service to Service MTLS
- REST Security
- API Gateway Security
Serverless Security
- Overview of Serverless Computing
- Serverless Security Considerations
- AWS Lambda
- Security Automation with Lambda
DEV540.5: Cloud Security Automation
Eric Johnson
Thu Sep 27th, 2018
Expanding on the foundation of the previous sections, we'll now focus on leveraging cloud services to automate security tasks such as deploying application patches to blue/green environments, deploying and configuring cloud web application firewalls, enabling cloud security monitoring, and automating cloud compliance scanning.
- Deploying Security Patches Using Blue/Green Environments
- Security Automation with the AWS WAF
- Security Monitoring and Alerting with CloudWatch and CloudTrail
- Automating Cloud Compliance with the CIS AWS Security Benchmark Project
CPE/CMU Credits: 6
Blue/Green Deployment Options
- EC2 DNS Routing
- EC2 Auto Scaling Groups
- ALB Launch Configuration
- ECS DNS Routing
- ECS Service Swapping
- ECS Task Definition
Security Automation
- Insufficient Attack Protection
- Cloud Web Application Firewalls
- AWS Security Automations Project
- Blocking Bat Bots with Honeypot Endpoints
- Writing a Custom WAF Rule
Security Monitoring
- Exploring CloudWatch Logs and Metrics
- Enabling CloudTrail for Audit Logging
- Cloud Monitoring Services
- Third-Party Cloud Monitoring Solutions
Cloud Compliance
- Compliance with AWS Artifact
- CSA Cloud Security Guidance Project
- CIS Cloud and Container Security Benchmarks
- AWS Security Benchmark Project
Additional Information
Laptop Requirements
Laptop Requirements
Plan to arrive early on Day 1 (8:00 AM local time) for lab preparation and setup. During this time you can confirm that your AWS account is properly set up, ensure that your laptop has virtualization enabled, copy the lab files, and start the Linux virtual machine.
The instructor will be available to assist students with laptop prep and set-up from 8:00AM - 9:00AM. Class lecture begins at 9:00 AM (excludes vLive, Mentor, and OnDemand).
It can take more than 24 hours for a new AWS free-tier account to become active. Please do the following at least one week prior to the start of class:
- Register for a personal free-tier account.
- Activate your new account.
- Log in to the AWS Console with your root account.
- Browse to the EC2 Service and verify that you see the dashboard (not an activation screen).
In the top right-hand corner of the page, select one the following supported regions (preferably the region closest to where the course is running):
- U.S. East (Northern Virginia
- U.S. West (Oregon)
- E.U. (Ireland)
- Asia Pacific (Tokyo)
- From the left navigation bar, select "Limits."
- Verify that you have at least 5 t2.micro instances available.
- If your limits are less than 5 t2.micro instances, request an increase to open a ticket with the AWS support team.
A properly configured system is required for each student participating in this course. Before coming to class, carefully read and follow these instructions exactly:
Download and install VMware Workstation, VMware Fusion, or VMware Workstation Player on your system prior to the start of the class.
- If you own a licensed copy of VMware, make sure it is at least VMware Workstation Pro 13.0, VMware Fusion 9.0, or VMware Workstation Player 13.0.
- If you do not own a licensed copy of VMware, download a free 30-day trial copy from VMware. VMware will send you a time-limited serial number if you register for the trial on its website.
Mandatory Host Hardware Requirements
- CPU: 64-bit 2.5+ GHz multi-core processor or higher
- Hard Disk: Solid-State Drive (SSD) is REQUIRED with 50GB of free disk space minimum
- Memory: 16GB of RAM minimum
- Working USB 2.0 or higher port
- You must have Local Administrator Access within your host operating system
- Windows Only: Verify that the BIOS settings have the Intel VT virtualization extensions enabled
Mandatory Host Operating System Requirements
You must bring a 64-bit laptop with one of the following operating systems that have been verified to be compatible with course VMware image:
- Windows (8 or 10)
- Mac OS X (El Capitan, Sierra, High Sierra)
Mandatory Software Requirements
Prior to class, ensure that the following software is installed on the host operating system:
- VMware Workstation Pro 13.0, VMware Fusion 9.0, or VMware Workstation Player 13.0
- Zip File Utility (7Zip or the built-in operating system zip utility)
In summary, before beginning the course you should:
- Bring a laptop with a solid-state drive (SSD), 16GB of RAM, and a 64-bit operating system.
- Install VMware (Workstation, Workstation Player, or Fusion).
- Windows Only: Verify that the BIOS settings have the Intel VT virtualization extensions enabled.
- Verify that the USB drive is active and capable of mounting an exFAT file system. (The course VM will be copied onto your laptop from a USB key provided by SANS.)
- Register a NEW AWS free-tier account prior to the start of the class at https://aws.amazon.com/.
Contact email@example.com with any questions about laptop specifications.
If you have additional questions about the laptop specifications, please contact firstname.lastname@example.com.
Who Should Attend
- Anyone working in or transitioning to a DevOps environment
- Anyone who wants to understand where to add security checks, testing, and other controls to DevOps and Continuous Delivery
- Anyone interested in learning to migrate DevOps workflows to the cloud, specifically Amazon Web Services (AWS)
- Anyone interested in leveraging cloud application security services provided by AWS
- Developers
- Software architects
- Operations engineers
- System administrators
- Security analysts
- Security engineers
- Auditors
- Risk managers
- Security consultants
- A basic understanding of application security, common attacks, and vulnerabilities (e.g., the OWASP Top 10)
- Familiarity with Agile development and Agile project/product management practices
- Familiarity with Linux command shells and associated commands
- Ability to understand basic coding concepts
Hands-on Labs
This course goes well beyond traditional lectures and delves into literal application of techniques, reinforcing learning through a number of hands-on labs. The labs will include a step-by-step guide to learning and applying hands-on techniques, but they also employ a "no hints" approach for those who want to stretch their skills and see how far they can get without following the guide. This allows each student, regardless of background, to choose a level of difficulty - always with a frustration-free fallback path.
What You Will Receive
- A course Virtual Machine (VM) containing pre-built DevOps CI/CD toolchain and lab exercises
- A USB drive containing course VM
- Course books
- A lab workbook
Authors Statement
"DevOps and cloud are radically changing the way that organizations design, build, deploy, and operate online systems. Leaders like Amazon, Etsy, and Netflix are able to deploy hundreds or even thousands of changes every day, continuously learning, improving, and growing - and leaving their competitors far behind. Now DevOps and the cloud are making their way from Internet 'Unicorns' and cloud providers into enterprises.
Traditional approaches to security can't come close to keeping up with this rate of accelerated change. Engineering and operations teams that have broken down the 'walls of confusion' in their organizations are increasingly leveraging new kinds of automation, including Infrastructure as Code, Continuous Delivery and Continuous Deployment, microservices, containers, and cloud service platforms. The question is: can security take advantage of the tools and automation to better secure its systems?"
Security must be reinvented in a DevOps and cloud world.
- Ben Allen, Jim Bird, Eric Johnson, and Frank Kim


text:
Lynn Collins doesn't have any movies playing in theaters.
If you feel like heading out, check out other movies in theaters.
Lost in the Sun
10 Years
John Carter
Angels Crest
Life in Flight
X-Men Origins: Wolverine
The Dog Problem
All Lynn Collins photos
All Lynn Collins films
Movies.com, the ultimate source for everything movies, is your destination for new movie trailers, reviews, photos, times, tickets + more! Stay in the know with the latest movie news and cast interviews at Movies.com.
Copyright © 2020 FANDANGO MOVIES.


text:
Spreadsheet Boot Camp – A Microsoft Excel Tutorial Based Entirely Inside Excel
Feedback Complete.
Spreadsheet Boot Camp is an entirely hands-on Excel tutorial that focuses on real-world applications.
Target Audience: 1st. College Students 2nd Young Professionals 3rd/Eventually Small companies with limited training budgets
Website URL: www.SpreadsheetBootCamp.com
No. of Feedback Providers Requested: 3


text:
"Splish splash, I was taking a bath," sang granola as it flopped around in some milk – content with his lot only until he saw something else going on in the kitchen.
"Wheeeeee!" screamed the pineapple while it hung in midair during an upside down flip.
"Yaahoooo!" cried the inverted plum, holding on tightly to a cinnamon cake as it swung around.
Granola looked up at me, pleading, "Can I go upside down, too?" "Of course, my friend!"
Granola Upside Down Cupcakes Recipe
For these granola upside down cupcakes, I adapted a vanilla sour cream cupcake recipe from Seriously Simple Holidays by Diane Rossen Worthington. My adaptation has a strong cinnamon flavor and a morning-with-coffee feel. (View on Amazon)
For the granola in these cupcakes, I used a homemade granola recipe. However, these upside down cupcakes would also work with store-bought granola (I provide instructions for using either granola). The granola will be slightly more moist in the homemade option because it starts off unbaked and bakes in the cupcake.
Granola Upside Down Cupcakes
- 1 1/4 C flour
- 1/2 tsp baking powder
- 1/4 tsp baking soda
- 1/4 tsp salt
- 2 tsp cinnamon
- 2 large eggs
- 1 C sugar
- 1/2 C unsalted butter room temperature
- 1 1/2 tsp vanilla extract
- 1/2 C sour cream
- 2 C granola You can use unbaked granola - from your own recipe or my granola recipe - or already baked homemade or store-bought granola. You could even use crumbled up granola bars.
- Lightly grease the bottom of a cupcake tin.
- Line the bottom of each cupcake holder with granola - about 1/4" thick (no need to break out your ruler - anywhere close to that is fine).
- If the granola is already baked (or store-bought), simply set the tin aside. If you are using a homemade granola recipe that you haven't baked, bake the cupcake tin with the granola at 350 F for ten minutes.
- Mix the flour, baking powder, baking soda, salt, and cinnamon in a medium-sized bowl and set aside.
- In a large bowl, with an electric mixer on medium speed, beat the eggs and sugar for about 2 minutes, or until light and creamy.
- Add the butter and vanilla and beat on low speed for about 1 minute, or until well blended.
- Beat in the dry ingredients on low speed until blended.
- Add the sour cream and beat until smooth and well blended.
- Spoon the cupcake batter over the granola-filled liners until the liners are each about halfway full.
- Bake at 350 F for about 20 minutes, or until a toothpick inserted into the center of a cupcake comes out clean and the tops are firm.
- Take the cupcakes out and turn them upside down. Listen for your granola screaming, "Yabba Dabba Doo!"


text:
This member has provided no bio about themself...
A Minecraft fan group! To buy the game visit there offical site at Minecraft.net
No groups were found matching the criteria specified. We suggest you try the group list with no filter applied, to browse all available. Start a group and help us achieve our mission of showcasing the best content from all developers. Join now to share your own content, we welcome creators and consumers alike and look forward to your comments.


text:
We Want to Build Your Business
At Installation Solutions, we know it's your vision that's gotten you this far, and we'd like to partner with you to realize the next phase of building your brand.
We believe that good project management takes more than a catchy slogan. It's the result of an ongoing commitment to integrity, a goal reached only through years of dedication and hard work.
In a fast-paced, constantly evolving business environment, quality project management is a moving target that requires a hands-on approach. That's why we utilize on-site quality assurance and experienced project Managers.
We Want to Join Your Team
Our dedicated staff will take your vision seriously and cater their approach to your specific build-out, redesign or remodel needs, from concept to completion and on into the future of your venture. Our success depends on yours, and we take that very seriously.


text:
Analogy is a trait thought to be uniquely human and the origin is largely unknown. Recent studies have suggested that some language trained apes can find relations between relations, which is thought to be what is at the root of analogy. However, a new study in the journal Psychological Science has tested baboons using shapes with matching features. These baboons were able to match pairs which had matching features and pairs which had no matching features.
The study was run by Joël Fagot of the Laboratoire de Psychologie Cognitive (CNRS/Université de Provence) and Roger Thompson of the Franklin & Marshall College (United States).
It has been hypothesised in the past that finding relations between relations is an ability only accessible by language, but these new findings with baboons cast doubt on this assertion.
The experiments were carried out on 29 baboons. The baboons were first shown two shapes on a screen. The baboons then touched one of these shapes and two other pairs of shapes appeared on the screen. To be successful at the task the baboons had to touch the pair representing the same relation as the initial pair. So if the first pair matched in a feature the baboon had to choose the pair which also had a matching feature, and avoid the pair where there was no matching feature, in order to gain a reward. This shows the inherent abilities behind analogy.
6 baboons correctly performed the task after thousands of trials of training showing that it is definitely within the abilities of old world monkeys to resolve analogy problems.
The researchers also revisited the same baboons with the same task a year later and the monkeys were much quicker at acquiring the task showing that they remembered what to do.
These results show that language is not necessary for analogy and leaves questions as to what might make this ability adaptive.
Fagot J, & Thompson RK (2011). Generalized Relational Matching by Guinea Baboons (Papio papio) in Two-by-Two-Item Analogy Problems. Psychological science PMID: 21934135